SCHEMBL9738796

SCHEMBL9738796

CCCn1nc(C(=O)NC2CCCCC2)nc1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.38
RIPK1 Q13546 2/20 0.37
SLC33A1 O00400 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9740009 0.99 AGTR1 (0.39) AGTR1RIPK1
SCHEMBL9739090 0.95 AGTR1 (0.44) AGTR1
SCHEMBL9738627 0.95 AGTR1 (0.44) AGTR1
SCHEMBL9738079 0.90 RIPK1 (0.34) RIPK1SLC33A1
SCHEMBL9739141 0.90 RIPK1 (0.37) RIPK1SLC33A1
SCHEMBL9738099 0.89 RIPK1 (0.35) AGTR1RIPK1SLC33A1
SCHEMBL9739505 0.89 RIPK1 (0.37) RIPK1SLC33A1
SCHEMBL9552245 0.88 AGTR1 (0.40) AGTR1SLC33A1
SCHEMBL9738294 0.88 AGTR1 (0.43) AGTR1
SCHEMBL9738567 0.87 AGTR1 (0.41) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO claimed
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO disclosed